191 related articles for article (PubMed ID: 26198406)
1. Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation.
Sundarasetty BS; Kloess S; Oberschmidt O; Naundorf S; Kuehlcke K; Daenthanasanmak A; Gerasch L; Figueiredo C; Blasczyk R; Ruggiero E; Fronza R; Schmidt M; von Kalle C; Rothe M; Ganser A; Koehl U; Stripecke R
J Transl Med; 2015 Jul; 13():240. PubMed ID: 26198406
[TBL] [Abstract][Full Text] [Related]
2. Engineered dendritic cells from cord blood and adult blood accelerate effector T cell immune reconstitution against HCMV.
Daenthanasanmak A; Salguero G; Sundarasetty BS; Waskow C; Cosgun KN; Guzman CA; Riese P; Gerasch L; Schneider A; Ingendoh A; Messerle M; Gabaev I; Woelk B; Ruggiero E; Schmidt M; von Kalle C; Figueiredo C; Eiz-Vesper B; von Kaisenberg C; Ganser A; Stripecke R
Mol Ther Methods Clin Dev; 2015; 1():14060. PubMed ID: 26052526
[TBL] [Abstract][Full Text] [Related]
3. Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo.
Daenthanasanmak A; Salguero G; Borchers S; Figueiredo C; Jacobs R; Sundarasetty BS; Schneider A; Schambach A; Eiz-Vesper B; Blasczyk R; Weissinger EM; Ganser A; Stripecke R
Vaccine; 2012 Jul; 30(34):5118-31. PubMed ID: 22691433
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
Peggs KS; Mackinnon S
Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation.
Micklethwaite KP; Clancy L; Sandher U; Hansen AM; Blyth E; Antonenas V; Sartor MM; Bradstock KF; Gottlieb DJ
Blood; 2008 Nov; 112(10):3974-81. PubMed ID: 18768783
[TBL] [Abstract][Full Text] [Related]
6. Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation.
Bialek-Waldmann JK; Heuser M; Ganser A; Stripecke R
Cancer Immunol Immunother; 2019 Nov; 68(11):1891-1899. PubMed ID: 31628525
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell-mediated immune humanization of mice: implications for allogeneic and xenogeneic stem cell transplantation.
Salguero G; Daenthanasanmak A; Münz C; Raykova A; Guzmán CA; Riese P; Figueiredo C; Länger F; Schneider A; Macke L; Sundarasetty BS; Witte T; Ganser A; Stripecke R
J Immunol; 2014 May; 192(10):4636-47. PubMed ID: 24740501
[TBL] [Abstract][Full Text] [Related]
8. Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ monocytes generates dendritic cells in vitro.
Koya RC; Weber JS; Kasahara N; Lau R; Villacres MC; Levine AM; Stripecke R
Hum Gene Ther; 2004 Aug; 15(8):733-48. PubMed ID: 15319031
[TBL] [Abstract][Full Text] [Related]
9. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells.
Abu-Khader A; Krause S
Eur J Haematol; 2013 Dec; 91(6):534-45. PubMed ID: 23952609
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell vaccination in an allogeneic stem cell recipient receiving a transplant from a human cytomegalovirus (HCMV)-seronegative donor: induction of a HCMV-specific T(helper) cell response.
Feuchtinger T; Opherk K; Bicanic O; Schumm M; Grigoleit GU; Hamprecht K; Jahn G; Handgretinger R; Lang P
Cytotherapy; 2010 Nov; 12(7):945-50. PubMed ID: 20230226
[TBL] [Abstract][Full Text] [Related]
11. Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- mice.
Salguero G; Sundarasetty BS; Borchers S; Wedekind D; Eiz-Vesper B; Velaga S; Jirmo AC; Behrens G; Warnecke G; Knöfel AK; Blasczyk R; Mischak-Weissinger E; Ganser A; Stripecke R
Hum Gene Ther; 2011 Oct; 22(10):1209-24. PubMed ID: 21574869
[TBL] [Abstract][Full Text] [Related]
12. Lentivirus-induced 'Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma.
Sundarasetty BS; Chan L; Darling D; Giunti G; Farzaneh F; Schenck F; Naundorf S; Kuehlcke K; Ruggiero E; Schmidt M; von Kalle C; Rothe M; Hoon DS; Gerasch L; Figueiredo C; Koehl U; Blasczyk R; Gutzmer R; Stripecke R
Gene Ther; 2015 Sep; 22(9):707-20. PubMed ID: 25965393
[TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
14. Leukoreduction system chambers are an efficient, valid, and economic source of functional monocyte-derived dendritic cells and lymphocytes.
Pfeiffer IA; Zinser E; Strasser E; Stein MF; Dörrie J; Schaft N; Steinkasserer A; Knippertz I
Immunobiology; 2013 Nov; 218(11):1392-401. PubMed ID: 23932569
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation.
Micklethwaite K; Hansen A; Foster A; Snape E; Antonenas V; Sartor M; Shaw P; Bradstock K; Gottlieb D
Biol Blood Marrow Transplant; 2007 Jun; 13(6):707-14. PubMed ID: 17531781
[TBL] [Abstract][Full Text] [Related]
16. Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapy.
Pincha M; Sundarasetty BS; Salguero G; Gutzmer R; Garritsen H; Macke L; Schneider A; Lenz D; Figueiredo C; Blasczyk R; Ruggiero E; Schmidt M; von Kalle C; Puff C; Modlich U; von der Leyen H; Wicke DC; Ganser A; Stripecke R
Hum Gene Ther Methods; 2012 Feb; 23(1):38-55. PubMed ID: 22428979
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of cytomegalovirus-specific T-cell response in allogeneic hematopoietic stem cell recipients: the contribution of six frequently recognized, virus-encoded ORFs.
Nemeckova S; Krystofova J; Babiarova K; Hainz P; Musil J; Sroller V; Maly M; Stastna-Markova M
Transpl Infect Dis; 2016 Jun; 18(3):381-9. PubMed ID: 27061389
[TBL] [Abstract][Full Text] [Related]
18. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
[TBL] [Abstract][Full Text] [Related]
19. Manufacturing of highly functional and specific T cells for adoptive immunotherapy against virus from granulocyte colony-stimulating factor-mobilized donors.
Beloki L; Ramírez N; Olavarría E; Samuel ER; Lowdell MW
Cytotherapy; 2014 Oct; 16(10):1390-408. PubMed ID: 24954783
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
